Arginase blockade protects against hepatic damage in warm ischemia-reperfusion

Nitric Oxide - Biology and Chemistry

Volumn 19, Issue 1, 2008, Pages 29-35

  Jeyabalan, Geetha ^a   Klune, John R ^a   Nakao, Atsunori ^a   Martik, Nicole ^a   Wu, Guoyao ^b   Tsung, Allan ^a   Geller, David A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Arginase; Arginine; Inflammation; Ischemia reperfusion; Liver; Nitric oxide

Indexed keywords

AMINO ACID; ARGINASE; ARGINASE INHIBITOR; ENZYME INHIBITOR; N OMEGA HYDROXY LEVO ARGININE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER INJURY; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACIDS; ANIMALS; ARGINASE; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INTERLEUKIN-6; LIVER DISEASES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; REPERFUSION INJURY; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTORS; WARM ISCHEMIA;

ANIMALIA; MUS;

EID: 45949105789     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.04.002     Document Type: Article

References (34)

1. Clavien P.A., Rudiger H.A., and Selzner M. Mechanism of hepatocyte death after ischemia: apoptosis versus necrosis. Hepatology 33 (2001) 1555-1557
2. Fondevila C., Busuttil R.W., and Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury-a fresh look. Exp. Mol. Pathol. 74 (2003) 86-93
3. Selzner N., Rudiger H., Graf R., and Clavien P.A. Protective strategies against ischemic injury of the liver. Gastroenterology 125 (2003) 917-936
4. Yokoyama Y., Nimura Y., Nagino M., Bland K., and Chaudry I. Role of thromboxanes in producing hepatic injury during hepatic stress. Arch. Surg. 140 (2005) 801-807
5. Clemens M., Bauer M., Pannen B., Bauer I., and Zhang J. Remodeling of hepatic microvascular responsiveness after ischemia/reperfusion. Shock 8 (1997) 80-85
6. Lee V.G., Johnson M.L., Baust J., Laubach V.E., Watkins S.C., and Billiar T.R. The roles of iNOS in liver ischemia-reperfusion injury. Shock 16 (2001) 355-360
7. Taylor B., and Geller D. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13 (2000) 413-424
8. Murphy H., Waner R., Bakopoulos N., Dame M., Varani J., and Ward P. Endothelial cell determinants of susceptibility to neutrophil-mediated killing. Shock 12 (1999) 111-117
9. Pryor W., and Squadrito G. A product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268 (1995) L699-L722
10. Langle F., Roth E., Steininger R., Winkler S., and Muhlbacher F. Arginase release following liver reperfusion. Evidence of hemodynamic action of arginase infusions. Transplantation 59 (1995) 1542-1549
11. Ochoa J.B., Bernard A.C., Mistry S.K., Morris S.M., Figert P.L., Maley M.E., Tsuei B.J., Boulanger B.R., and Kearney P.A. Trauma increases extrahepatic arginase activity. Surgery 12 (2000) 419-426
12. Calabrese F., Valente M., Pettenazzo E., Ferraresso M., Burra P., Cadrobbi R., Cardin R., Bacelle L., Parnigotto A., and Rigotti P. The protective effects of l-arginine after liver ischemia-reperfusion injury in a pig model. Plant J. Pathol. 183 (1997) 477-485
13. Yagnik G.P., Takahashi Y., Tsoulfas G., Reid K., Murase N., and Geller D.A. Blockade of the l-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 36 (2002) 573-581
14. Boucher J.L., Custot J., Vadon S., Delaforge M., Lepoivre M., Tenu J.P., Yapo A., and Mansuy D. N-omega-hydroxyl-l-arginine, an intermediate in the l-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun. 203 (1994) 1614-1621
15. Moali C., Boucher J.L., Sari M.A., Stuehr D.J., and Mansuy D. Substrate specificity of NO synthases: detailed comparison of l-arginine, their N-omega-hydroxy derivatives, and N-omega-hydroxy-nor-l-arginine. Biochem. J. 37 (1998) 10453-10460
16. Custot J., Moali C., Brollo M., Boucher J.L., Delaforge M., Mansuy D., Tenu J.P., and Zimmerman J.L. The new amino acid N-omega-hydroxy-no-l-arginine: a high-affinity inhibitor of arginase well adapted to bind to its manganese cluster. J. Am. Chem. Soc. 119 (1997) 4086-4087
17. Tenu J.P., Lepoivre M., Moali C., Brollo M., Mansuy D., and Boucher J.L. Effects of the new arginase inhibitor N[omega]-hydroxy-non-arginine on NO synthase activity in murine macrophages. Nitric Oxide 3 (1999) 427-438
18. Xian M., Fujiwara N., Wen Z., Cai T., Kazum S., Janczuk A.J., Tang X., Telyatnikov V.V., Zhang Y., Chen X., Miyamoto Y., Taniguchi N., and Wang P.G. Novel substrates for nitric oxide synthases. Bioorg. Med. Chem. 10 (2002) 3049-3055
19. Reid K., Tsung A., Kaizu T., Jeyabalan G., Ikeda A., Shao L., Wu G., Murase N., and Geller D.A. Liver I/R injury is improved by the arginase inhibitor, N-omega-hydroxy-nor-l-arginine (nor-NOHA). Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2006) G512-G517
20. Morris Jr. S.M., Kepka-Lenhart D., and Chen L.C. Differential regulation of arginase and inducible nitric oxide synthase in murine macrophage cells. Am. J. Physiol. 275 (1998) 740-747
21. Moore B.A., Otterbein L.E., Turler A., Choi A.M., and Bauer A.J. Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine. Gastroenterology 124 (2003) 377-391
22. Overbergh L., Valckx D., Waer M., and Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11 (1999) 305-312
23. Corraliza I.M., Campo M.L., Soler G., and Modolell M. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174 (1994) 231-235
24. Konarska L., and Tomaszewski L. A simple quantitative micromethod of arginase assay in blood spots dried on filter paper. Clin. Chim. Acta 154 (1986) 7-18
25. Wu G., Flynn N.E., and Knabe D.A. Enhanced intestinal synthesis of polyamines from proline in cortisol-treated piglets. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E395-E402
26. Langle F., Steininger R., Waldmann E., Grunberger T., Benditte H., Mittlbock M., Soliman T., Schindl M., Windberger U., Muhlbacher F., and Roth E. Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of l-arginine during the early reperfusion period in pig liver transplantation. Transplantation 63 (1997) 1225-1233
27. Kaizu T., Nakao A., Tsung A., Toyokawa H., Sahai R., Geller D., and Murase N. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery 138 (2005) 229-235
28. M.C. van de Poll, S.J. Hanssen, M. Berbee, N.E. Deutz, D. Monbaliu, W.A. Buurman, C.H. Dejong, Elevated plasma arginase-1 does not affect plasma arginine in patients undergoing liver resection, Clin. Sci. (Lond.), 2007.
29. Wu G., and Morris Jr. S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (1998) 1-17
30. Flynn N.E., Meininger C.J., Haynes T.E., and Wu G. The metabolic basis of arginine nutrition and pharmacotherapy. Biomed. Pharmacother. 56 (2002) 427-438
31. Zanovella P., and Bronte V. Regulation of immune responses by l-arginine metabolism. Nat. Rev. Immunol. 5 (2005) 641-654
32. Wu G. Intestinal mucosal amino acid catabolism. J. Nutr. 128 (1998) 1249-1252
33. Corraliza I.M., Soler G., Eichmann K., and Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10, and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206 (1995) 667-673
34. Rodriguez P.C., Quiceno D.G., Zabaleta J., Ortiz B., Zea A.H., Piazuelo M.B., Delgado A., Correa P., Brayer J., Sotomayor E.M., Antonia S., Ochoa J.B., and Ochoa A.C. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64 (2006) 5839-5849